These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci. Pascual A, Martínez-Martínez L, Perea EJ. Chemotherapy; 1989; 35(1):17-22. PubMed ID: 2721289 [Abstract] [Full Text] [Related]
3. [Comparative study on growth kinetics of organisms causing purulent infections in the presence of ofloxacin and ciprofloxacin]. Skala LZ. Antibiot Khimioter; 1991 Nov; 36(11):21-4. PubMed ID: 1793289 [Abstract] [Full Text] [Related]
4. Mutation rates to 4-quinolone resistance. Smith JT. Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135 [Abstract] [Full Text] [Related]
5. [Study of quinolones resistance in Escherichia coli, Staphylococcus aureus and Pseudomonas areuginosa]. Feng P, Yu R, Xia P, Lü X, Zhu S. Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):501-4. PubMed ID: 12528531 [Abstract] [Full Text] [Related]
6. Effect of ciprofloxacin on phagocytosis. Forsgren A, Bergkvist PI. Eur J Clin Microbiol; 1985 Dec; 4(6):575-8. PubMed ID: 2936604 [Abstract] [Full Text] [Related]
7. Bactericidal effect of polymorphonuclear leukocytes on Pseudomonas aeruginosa pre-incubated in ofloxacin. Nielsen B, Nielsen H. Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):227-32. PubMed ID: 3118637 [Abstract] [Full Text] [Related]
8. Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro. Kim SY, Lim JA, Choi JS, Choi EC, Joo CK. Cornea; 2007 Jul; 26(6):720-5. PubMed ID: 17592324 [Abstract] [Full Text] [Related]
9. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin. Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE. Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375 [Abstract] [Full Text] [Related]
11. Investigations on ofloxacin: antibacterial activity and influence on the immune system. Pulverer G, Peters G. Infection; 1986 Mar; 14 Suppl 4():S245-7. PubMed ID: 3102386 [Abstract] [Full Text] [Related]
12. Does the appearance of drug resistance during therapy alter bacterial susceptibility to opsonophagocytosis? Gemmell CG. Drugs Exp Clin Res; 1996 Mar; 22(2):51-5. PubMed ID: 8879979 [Abstract] [Full Text] [Related]
14. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants. Cullmann W, Stieglitz M, Baars B, Opferkuch W. Chemotherapy; 1985 Mar; 31(1):19-28. PubMed ID: 3156025 [Abstract] [Full Text] [Related]